Cargando…
Recent Advances and Challenges in Uveal Melanoma Immunotherapy
SIMPLE SUMMARY: Uveal melanoma is the most common primary intraocular malignancy in adults. Although it can be controlled locally, half of the patients still develop metastases. To date, there have been no standard therapeutic strategies for the prevention or treatment of metastases. Existing therap...
Autores principales: | Fu, Yihang, Xiao, Wei, Mao, Yuxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264803/ https://www.ncbi.nlm.nih.gov/pubmed/35804863 http://dx.doi.org/10.3390/cancers14133094 |
Ejemplares similares
-
Recent advancements in the management of retinoblastoma and uveal melanoma
por: Schefler, Amy C, et al.
Publicado: (2018) -
Recent advancements in the management of retinoblastoma and uveal melanoma
por: Schefler, Amy C, et al.
Publicado: (2021) -
Immunotherapies for the Treatment of Uveal Melanoma—History and Future
por: Schank, Timo E., et al.
Publicado: (2019) -
Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
por: Castet, Florian, et al.
Publicado: (2019) -
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019)